Useful resources |
Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk (Cochrane Review) ABSTRACT Background: Second malignancies (SM) are a major late effect of treatment for Hodgkin's disease (HD). Reliable comparisons of SM risk between alternative treatment strategies are lacking. |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |